V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Debut trading of AbCellera Biologics, Inc.

12.12.2020

In their debut trading on Friday, December 11 AbCellera Biologics, Inc. (ABCL) showed a 194.50 % and closed at $58.90 per share. Shortly before the company had placed its shares in an IPO priced $20 per share.